+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Acura Pharmaceuticals Inc - logo

Acura Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of deterrents to medication abuse and misuse. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to pain and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants. The company was founded in 1935 and is based in Palatine, Illinois.

Opioid Drugs: Global Markets to 2023 - Product Thumbnail Image

Opioid Drugs: Global Markets to 2023

  • Report
  • November 2018
  • 147 Pages
  • Global
From
Opioid Receptor Agonists - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid Receptor Agonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • March 2024
  • 1300 Pages
  • Global
From
Abuse Deterrent Formulation Technologies Market, 2019-2030 - Product Thumbnail Image

Abuse Deterrent Formulation Technologies Market, 2019-2030

  • Report
  • July 2019
  • 280 Pages
  • Global
From
Central Nervous System Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Central Nervous System Collaboration and Licensing Deals 2019-2024

  • Report
  • April 2024
  • 700 Pages
  • Global
From
Cough Hypersensitivity Syndrome Global Market Report 2024 - Product Thumbnail Image

Cough Hypersensitivity Syndrome Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Contract Manufacturing Service Agreements - Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion - Product Thumbnail Image

Contract Manufacturing Service Agreements - Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion

  • Report
  • July 2020
  • 51 Pages
  • Global
From
Acura Pharmaceuticals Inc (ACUR:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

Acura Pharmaceuticals Inc (ACUR:PINX): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • May 2023
  • 88 Pages
From
Acura Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Acura Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • April 2024
  • 50 Pages
From
Acura Pharmaceuticals Inc (ACUR) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Acura Pharmaceuticals Inc (ACUR) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • February 2023
  • 37 Pages
From
  • 10 Results (Page 1 of 1)
Loading Indicator